Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

Plataforma ISCIII de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Joan Genescà Ferrer, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 315150
Reference: PT20/00078
Duration: 01/01/2021 - 31/12/2024

ACTUALIZACIÓN DE EQUIPAMIENTOS DE ALTA TECNOLOGIA PARA LA PLATAFORMA DE IMAGEN PRECLINICA. ADQUISICION DE UN EQUIPO DE ULTRASONIDOS DE INVESTIGACION PRECLINICA

IP: Inmaculada Fuentes Camps
Collaborators: Diego Arango Corro, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Francesc Bosch Albareda, Victor Franco Puntes, José Raul Herance Camacho, Jordi Giralt López de Sagred, Màrius Aguirre Canyadell, Xavier Serres Créixams, Simon Schwartz Navarro, Joaquim Mateo Valderrama, Mario Marotta Baleriola, Anna Rosell Novel, Joan Genescà Ferrer
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 108390
Reference: EQC2019-006322-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

Estudio de enfermedades vasculares hepáticas

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 82400
Reference: FI19/00330
Duration: 01/01/2020 - 31/12/2023

Partida para intensificació durant la 2a i 3a anualitat

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: PI18/00947_INT_GENESCA
Duration: 02/03/2020 - 30/06/2023

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Antonio Luis Andreu Périz

Antonio Luis Andreu Périz

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Navas Moya, Elisabeth

Navas Moya, Elisabeth

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Pulido Salgado, Marta

Pulido Salgado, Marta

Administration and Management
Clinical Neuroimmunology
Read more
Lluis Castells Fusté

Lluis Castells Fusté

Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.